A. CANGA Et Al. , "Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia," International Journal of Clinical Research , vol.1, no.1, pp.5-9, 2013
CANGA, A. Et Al. 2013. Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia. International Journal of Clinical Research , vol.1, no.1 , 5-9.
CANGA, A., KOCAMAN, S. A., ÇETİN, M., KIRBAŞ, A., DURAKOGLUGIL, M. E., ERDOĞAN, T., ... TEMIZ, A.(2013). Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia. International Journal of Clinical Research , vol.1, no.1, 5-9.
CANGA, A. Et Al. "Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia," International Journal of Clinical Research , vol.1, no.1, 5-9, 2013
CANGA, A. Et Al. "Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia." International Journal of Clinical Research , vol.1, no.1, pp.5-9, 2013
CANGA, A. Et Al. (2013) . "Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia." International Journal of Clinical Research , vol.1, no.1, pp.5-9.
@article{article, author={A. CANGA Et Al. }, title={Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Activity In Patients with Isolated Coronary Artery Ectasia}, journal={International Journal of Clinical Research}, year=2013, pages={5-9} }